Research Article
Larix laricina, an Antidiabetic Alternative Treatment from the Cree of Northern Quebec Pharmacopoeia, Decreases Glycemia and Improves Insulin Sensitivity In Vivo
Table 1
Effects of HFD and L. laricina administration on systemic parameters at sacrifice.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Measurements were obtained after 8 weeks (prevention) or 16 weeks (treatment) of administration with either HFD (DIO) or L. laricina at 125 or 250 mg/kg, which was incorporated in the HFD for 8 weeks in the prevention protocol and for the last 8 of 16 weeks in the treatment protocol. All values represent the mean ± SEM (prevention protocol DIO = 11; L. laricina 125 = 13; L. laricina 250 = 13, and for the treatment protocol DIO = 7; L. laricina 125 = 5; L. laricina 250 = 8). *denotes that treated groups are significantly different as compared to DIO (one-way ANOVA; post hoc analysis Holm-Sidak or Bonferroni-Dunn test; ). |